Alnylam Pharmaceuticals (ALNY) Q4 2025 Earnings

Oct 30Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.89
0.02
0.93
1.84

Details

Expected EPS
0.560954
Actual EPS
1.84
Surprise EPS
1.28
Surprise Percent
+228.01%

Description

⁨Alnylam Pharmaceuticals⁩ (⁦ALNY⁩) has reported earnings of ⁦1.84⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts